Clinical Trial Update: HMB Supplementation and Motor Performance in Sarcopenic Patiens [NA]

View source ↗

Summary

The entry notes a clinical trial evaluating HMB supplementation to improve motor performance in sarcopenic patients, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Drugs mentioned

• HMB supplementation (beta-hydroxy beta-methylbutyrate (HMB))

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Sarcopenia | NA | Status: NOT_YET_RECRUITING